Xiaofei Li

2.1k total citations
43 papers, 797 citations indexed

About

Xiaofei Li is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Xiaofei Li has authored 43 papers receiving a total of 797 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pulmonary and Respiratory Medicine, 22 papers in Oncology and 7 papers in Surgery. Recurrent topics in Xiaofei Li's work include Lung Cancer Treatments and Mutations (21 papers), Lung Cancer Research Studies (13 papers) and Lung Cancer Diagnosis and Treatment (9 papers). Xiaofei Li is often cited by papers focused on Lung Cancer Treatments and Mutations (21 papers), Lung Cancer Research Studies (13 papers) and Lung Cancer Diagnosis and Treatment (9 papers). Xiaofei Li collaborates with scholars based in China, Netherlands and United States. Xiaofei Li's co-authors include Weimin Mao, Chun Chen, Lanjun Zhang, Shidong Xu, Yi Shen, Heng Zhao, Qun Wang, Yongyu Liu, Dongsheng Yue and Yue Yang and has published in prestigious journals such as Journal of Clinical Oncology, Nano Letters and Annals of Oncology.

In The Last Decade

Xiaofei Li

42 papers receiving 788 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaofei Li China 17 428 344 162 144 142 43 797
Lama Sakr Canada 13 471 1.1× 212 0.6× 142 0.9× 110 0.8× 78 0.5× 30 789
Nikolaos Charalampakis Greece 12 305 0.7× 511 1.5× 213 1.3× 270 1.9× 163 1.1× 42 988
Ming‐Shen Dai Taiwan 17 171 0.4× 278 0.8× 57 0.4× 206 1.4× 94 0.7× 71 771
Marc Hilmi France 15 123 0.3× 421 1.2× 128 0.8× 171 1.2× 128 0.9× 34 716
Anna Compagnoni Italy 13 207 0.5× 351 1.0× 68 0.4× 180 1.3× 103 0.7× 19 840
Motoki Yoshida Japan 14 511 1.2× 335 1.0× 171 1.1× 112 0.8× 97 0.7× 34 956
Yidong Cai China 7 223 0.5× 263 0.8× 358 2.2× 222 1.5× 105 0.7× 9 815
Motoyasu Kato Japan 15 690 1.6× 496 1.4× 66 0.4× 362 2.5× 267 1.9× 51 1.2k
Khurum Khan United Kingdom 13 205 0.5× 304 0.9× 217 1.3× 165 1.1× 86 0.6× 32 672

Countries citing papers authored by Xiaofei Li

Since Specialization
Citations

This map shows the geographic impact of Xiaofei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofei Li more than expected).

Fields of papers citing papers by Xiaofei Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaofei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofei Li. The network helps show where Xiaofei Li may publish in the future.

Co-authorship network of co-authors of Xiaofei Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaofei Li. A scholar is included among the top collaborators of Xiaofei Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaofei Li. Xiaofei Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Li, Xiaofei, Qian Liu, Yan Li, et al.. (2024). Ultrasmall Prussian Blue Nanozyme Attenuates Osteoarthritis by Scavenging Reactive Oxygen Species and Regulating Macrophage Phenotype. Nano Letters. 24(37). 11697–11705. 22 indexed citations
3.
Cheng, Ying, Caicun Zhou, Xuhong Min, et al.. (2023). 84P Adebrelimab plus chemotherapy (chemo) as first-line treatment for extensive-stage small-cell lung cancer (ES-SCLC): 3-year update of the phase III CAPSTONE-1 study. Immuno-Oncology Technology. 20. 100556–100556. 2 indexed citations
4.
5.
Zhao, Sha, Yan Zhu, Minhong Pan, et al.. (2022). [Clinicopathological features of clear cell carcinoma of salivary gland in the head and neck].. PubMed. 51(6). 494–499. 1 indexed citations
6.
7.
Huo, Yan, et al.. (2021). Predictive efficacy of weaning index on mechanical ventilation evacuation. Annals of Palliative Medicine. 10(1). 646–656. 4 indexed citations
8.
Li, Xiaofei, et al.. (2020). [Clinicopathological study of large B-cell lymphoma with IRF4 rearrangement].. PubMed. 49(10). 1003–1008. 2 indexed citations
9.
Xiao, Zheng, Cheng-Qiong Wang, Lianhong Li, et al.. (2018). Clinical Efficacy and Safety of Aidi Injection Plus Docetaxel‐Based Chemotherapy in Advanced Nonsmall Cell Lung Cancer: A Meta‐Analysis of 36 Randomized Controlled Trials. Evidence-based Complementary and Alternative Medicine. 2018(1). 16 indexed citations
10.
11.
Sun, Ying, Xuejiao Wang, Xianghui Fu, et al.. (2018). Combination of EGFR-TKIs with chemotherapy versus chemotherapy or EGFR-TKIs alone in advanced NSCLC patients with EGFR mutation. Biologics. Volume 12. 183–190. 21 indexed citations
12.
13.
Li, Xiaofei, Tao Wang, Liang Yao, et al.. (2017). The safety and effectiveness of robot-assisted versus laparoscopic TME in patients with rectal cancer. Medicine. 96(29). e7585–e7585. 55 indexed citations
14.
Guo, Kang, Wuping Wang, Tao Jiang, et al.. (2016). Assessment of epidermal growth factor receptor mutation/copy number and K-ras mutation in esophageal cancer. Journal of Thoracic Disease. 8(7). 1753–1763. 13 indexed citations
15.
Sun, Ying, Yong Han, Xiaoping Wang, et al.. (2016). Correlation of EGFR Del 19 with Fn14/JAK/STAT signaling molecules in non-small cell lung cancer. Oncology Reports. 36(2). 1030–1040. 24 indexed citations
16.
Wang, Xuejiao, et al.. (2016). Detection of EML4-ALK fusion gene and features associated with EGFR mutations in Chinese patients with non-small-cell lung cancer. OncoTargets and Therapy. 9. 1989–1989. 19 indexed citations
17.
Yang, Yan, Xiufang Cui, Yaqiang Wang, et al.. (2014). Exendin-4, an analogue of glucagon-like peptide-1, attenuates hyperalgesia through serotonergic pathways in rats with neonatal colonic sensitivity.. PubMed. 65(3). 349–57. 23 indexed citations
18.
Knaapen, Max, Charlotte Koch, Karel T. Koch, et al.. (2012). Prevalence of left and balanced coronary arterial dominance decreases with increasing age of patients at autopsy. A postmortem coronary angiograms study. Cardiovascular Pathology. 22(1). 49–53. 32 indexed citations
19.
Liu, Wenchao, Xiaofei Li, Zhipei Zhang, et al.. (2012). Detection of EGFR Mutation in Tissue Samples of Non–small-cell Lung Cancer by a Fluorescence Polarization Assay. Diagnostic Molecular Pathology. 21(3). 138–142. 4 indexed citations
20.
Li, Yan, Rong‐Miao Zhou, Na Wang, et al.. (2009). Association of p73 and MDM2 polymorphisms with the risk of epithelial ovarian cancer.. Tumori. 29(9). 892–897. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lama Sakr Breakdown of academic impact, for papers by Nikolaos Charalampakis Breakdown of academic impact, for papers by Ming‐Shen Dai Breakdown of academic impact, for papers by Marc Hilmi Breakdown of academic impact, for papers by Anna Compagnoni Breakdown of academic impact, for papers by Motoki Yoshida Breakdown of academic impact, for papers by Yidong Cai Breakdown of academic impact, for papers by Motoyasu Kato Breakdown of academic impact, for papers by Khurum Khan
Rankless by CCL
2026